These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19022151)

  • 61. [Osteonecrosis of the jaw].
    Eriksen EF
    Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862
    [No Abstract]   [Full Text] [Related]  

  • 62. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract]   [Full Text] [Related]  

  • 63. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
    Favia G; Pilolli GP; Maiorano E
    J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
    Tong CK; Ho ST; Wong SL
    Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
    Van Poznak C
    Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Higher bone matrix density exists in only a subset of patients with bisphosphonate-related osteonecrosis of the jaw.
    Allen MR; Ruggiero SL
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1373-7. PubMed ID: 19531405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bisphosphonate medications--the good, the bad, and the ugly.
    Bourgeois SL
    Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
    [No Abstract]   [Full Text] [Related]  

  • 68. Osteonecrosis of the jaw.
    Sykes DL
    Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272
    [No Abstract]   [Full Text] [Related]  

  • 69. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
    Geist RY; Geist JR; Aksu M
    J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
    [No Abstract]   [Full Text] [Related]  

  • 70. Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation.
    Elad S; Gomori MJ; Ben-Ami N; Friedlander-Barenboim S; Regev E; Lazarovici TS; Yarom N
    Clin Oral Investig; 2010 Feb; 14(1):43-50. PubMed ID: 19603201
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients.
    Wass JA
    Clin Radiol; 2008 Jan; 63(1):78-9. PubMed ID: 18068793
    [No Abstract]   [Full Text] [Related]  

  • 72. Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient.
    Ruggiero SL; Carlson ER; Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):1. PubMed ID: 19371808
    [No Abstract]   [Full Text] [Related]  

  • 73. Bone drugs may harm what they're supposed to protect. The bisphosphonate drugs have been linked to death of bone tissue.
    Harv Health Lett; 2006 Sep; 31(11):6-7. PubMed ID: 17136805
    [No Abstract]   [Full Text] [Related]  

  • 74. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
    Williamson RA
    Int J Oral Maxillofac Surg; 2010 Mar; 39(3):251-5. PubMed ID: 20015614
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
    Treister NS; Friedland B; Woo SB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):753-64. PubMed ID: 20303301
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bone-within-bone appearance: a red flag for biphosphonate-associated osteonecrosis of the jaw.
    Fatterpekar GM; Emmrich JV; Eloy JA; Aggarwal A
    J Comput Assist Tomogr; 2011; 35(5):553-6. PubMed ID: 21926848
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.
    Stockmann P; Hinkmann FM; Lell MM; Fenner M; Vairaktaris E; Neukam FW; Nkenke E
    Clin Oral Investig; 2010 Jun; 14(3):311-7. PubMed ID: 19513765
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelet-rich plasma: an adjunctive treatment modality for bisphosphonate osteonecrosis?
    Badr MS; Oliver RJ
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1357. PubMed ID: 19446237
    [No Abstract]   [Full Text] [Related]  

  • 79. [Diagnostic value of chromato-mass-spectrometry in patients with drug-induced jaws osteonecrosis].
    Ivanyushko TP; Simonova AV; Polyakov KA; Kunizheva MA
    Stomatologiia (Mosk); 2019; 98(3):42-45. PubMed ID: 31322593
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the Er:YAG laser.
    Angiero F; Sannino C; Borloni R; Crippa R; Benedicenti S; Romanos GE
    Lasers Med Sci; 2009 Nov; 24(6):849-56. PubMed ID: 19277823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.